Bio-Techne Corp

(TECH) Trade

By |

Profile

Bio-Techne Corp is a life science manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The protein sciences division's key products (78% of sales) include proteins, antibodies, and assays as well as equipment and associated consumables for protein characterization and analysis. The remaining revenue in the diagnostics and genomics segment is roughly split between manufacturing creates controls, calibrators, and reagents for diagnostic manufacturers combined with proprietary molecular and genetic testing kits. The company is split into two reporting segments namely, Protein Sciences segment and Diagnostics and Genomics segment. The Protein Sciences segment generates maximum revenue for the company.

Contact Information

Website: www.bio-techne.com
Email: techinfo@techne-corp.com
Main Phone: +1 612 379-8854
Address: 614 McKinley Place N.E
State: MN
City / Town: Minneapolis
Country: USA
Postal Code: 55413

Issuer Information

Exchange: NGS
CEO: Charles R. Kummeth
Employees: 2250
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

Profile

Bio-Techne Corp is a life science manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The protein sciences division's key products (78% of sales) include proteins, antibodies, and assays as well as equipment and associated consumables for protein characterization and analysis. The remaining revenue in the diagnostics and genomics segment is roughly split between manufacturing creates controls, calibrators, and reagents for diagnostic manufacturers combined with proprietary molecular and genetic testing kits. The company is split into two reporting segments namely, Protein Sciences segment and Diagnostics and Genomics segment. The Protein Sciences segment generates maximum revenue for the company.

Contact Information

Website: www.bio-techne.com
Email: techinfo@techne-corp.com
Main Phone: +1 612 379-8854
Address: 614 McKinley Place N.E
State: MN
City / Town: Minneapolis
Country: USA
Postal Code: 55413

Issuer Information

Exchange: NGS
CEO: Charles R. Kummeth
Employees: 2250
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

$ 272.40 $ -4.97 (-1.79%)
Last Price 272.40 Change $ -4.97 Change % -1.79 Tick N/A
Bid 234.00 Bid Size 100.00 Ask N/A Ask Size 0.00
Open 278.20 High 278.53 Low 271.54 Prev Close 277.37
Last Trade Volume 135,903 52 Wk Hi 282.52 52 Wk Low 155.17
Market Cap 10.4 bi Ex-Div Date Div Rate 1.28 Yield 0.4700
Shares 38,223,009.00 EPS (TTM) 4.73 PE Ratio 57.60 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 25
Number of Buys 0 12
Number of Sells 2 13
Net Activity -9136 17635
Last 10 Buys Shares
Howard V. O'Connell 1,000
Robert V. Baumgartner 1,000
Last 10 Sell Shares
Charles R. Kummeth 1,000
N. David Eansor 1,000
Charles A. Dinarello 1,000
Charles A. Dinarello 1,000
Robert V. Baumgartner 1,000
Roger C. Lucas 1,000
Roger C. Lucas 1,000
Karen A. Holbrook 1,000
Roger C. Lucas 1,000
Roger C. Lucas 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 165 165 165 165
Low Target Price Estimate 148 142 142 148
Mean Target Price Estimate 157.8 155.4 155.4 157.8
Standard Deviation 6.8 9.89 9.89 6.8
Date of Most Recent Estimate 06/04/18 05/03/18 05/03/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 2 2 2 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.5 1.5 1.67